Oneok upgraded at Wolfe, as discounted valuation brings buying opportunity
Oneok upgraded at Wolfe Research, saying the stock has fallen out of favor on near-term Bakken headwinds and its valuation has quickly shifted to a big discount to large-cap peers.
Wolfe Research maintains Charles Schwab Outperform rating
Wolfe Research reiterated its Outperform rating on Charles Schwab Corporation (NYSE:SCHW), a $148 billion financial services giant with an impressive 96.99% gross profit margin, maintaining a steady ...
Triumph Group downgraded to Peer Perform from Outperform at Wolfe Research
Wolfe Research analyst Myles Walton downgraded Triumph Group (TGI) to Peer Perform from Outperform without a price target after the company ...
Spinoff trends like Honeywell's will continue, says Wolfe Research's Chris Senyek
CNBC’s Seema Mody and Chris Senyek, Wolfe Research chief investment strategist, join 'Power Lunch' to discuss the Honeywell ...
D-Wave Quantum (QBTS): ‘Quantum Realized’ Conference Showcases Real-World AI Impact
We recently published a list of 12 AI News and Ratings Investors are Keeping Their Eye On. In this article, we are going to ...
Cash App, Venmo app downloads decline
Consumer downloads of apps like Cash App and Venmo dropped in the fourth quarter compared to the year-ago period, data from ...
Should Comcast split into three? This analyst says a breakup would mean big upside.
Today he's back with another open letter urging management to separate into three businesses. "Three public companies with ...
Vera Therapeutics initiated with an Outperform at Wolfe Research
Wolfe Research initiated coverage of Vera Therapeutics (VERA) with an Outperform rating and $49 price target The firm is bullish on the stock ...
Investing8d
"He really did it": Wolfe Research weighs in on the impact of Trump's new tariffs
Investing.com - U.S. President Donald Trump's decision to impose tariffs on America's closest trading partners means that ...